Description
- Composition: Retatrutide 20 mg
- Category: Peptide
- Purpose of use: Weight loss
- Form: Vial with lyophilized powder + 1 ml ampoule of injection solution for reconstitution
- Administration: Subcutaneous injections
What is Retatrutide?
Retatrutide is an experimental, peptide-based medication designed for weight loss and metabolic normalization. It works through a triple mechanism by activating the GLP-1, GIP, and glucagon receptors — hormones that regulate appetite, blood sugar, and energy expenditure. This unique combination currently makes it one of the most promising new candidates for the treatment of obesity and metabolic disorders.
And now, Retatrutide is finally available in our shop for those who want to explore its potential firsthand.
Who can benefit from Retatrutide?
✓ If you want to lose weight and control your appetite without extreme diets or starvation — Retatrutide reduces appetite and prolongs the feeling of satiety, helping you eat less and comfortably shed excess weight.
✓ If you have insulin resistance, metabolic syndrome, or prediabetes — the medication improves insulin sensitivity and supports blood sugar regulation.
✓ If you suffer from obesity and related conditions such as high blood pressure, fatigue, or inflammation — Retatrutide helps reduce the burden on internal organs and improves your metabolic profile.
✓ If you have been diagnosed with Type 2 diabetes — it can help better control blood sugar levels, reduce cravings, and serve as an additional therapeutic aid.
✓ If you want to prevent fatty liver disease — Retatrutide can lower liver fat content and reduce systemic inflammation.
How to take Retatrutide?
Retatrutide is supplied in a vial with 10 mg of lyophilized powder. It must be reconstituted with the provided injection water before use. You can find detailed instructions on preparing peptides and administering injections on our website.
Dosing schedule
Step: Start | Weekly Dose: 2.5 mg | Period: Weeks 1–4 | Hints: For adjustment and fewer side effects
Step: First increase | Weekly Dose: 5 mg | Period: Weeks 5–8 | Hints: If well tolerated
Step: Optional step | Weekly Dose: 7.5 mg | Period: Weeks 9–12 | Hints: Add if more effect is needed
Step: Usual range | Weekly Dose: 10–12.5 mg | Period: After week 12 | Hints: Most stay here for long-term benefit
Step: Maximum | Weekly Dose: 15 mg | Period: Until the goal is reached | Hints: Only if lower doses do not work and are well tolerated
- Administer once a week, always on the same day
- Visually check the solution before injection (it should be clear, without particles or deposits)
- If nausea or weakness occurs, slow down the dose escalation or take a 1-week break
Contraindications and precautions
- Do not use if you have a family history of medullary thyroid cancer or MEN2 syndrome
- Use with caution in cases of pancreatitis, gallbladder disease, or thyroid disorders
- Do not combine with medications that slow gastrointestinal motility without medical advice
Possible side effects
- Nausea (especially in the first few weeks)
- Loss of appetite
- Bloating, gas, soft stools, or constipation
- Fatigue, headache
- Rarely: elevated pancreatic enzymes, abdominal pain (discontinue if severe pain occurs)
How to store?
- Store the product in the refrigerator at 2–8 °C (36–46 °F).
- Do not freeze.
- Protect from light.
- Avoid frequent temperature fluctuations (e.g., repeatedly taking it out of the refrigerator).
- After reconstitution, store in the refrigerator and use within approximately one month.
How does Retatrutide work?
Retatrutide acts on three key hormonal receptors involved in food intake and metabolic regulation: GLP-1, GIP, and the glucagon receptor. Their combined activation leads to appetite suppression, improved glucose management, and enhanced fat breakdown.
GLP-1
GLP-1 (glucagon-like peptide-1) is a hormone released by the gut after eating. It signals the brain that the body has taken in enough food, which promotes early satiety and reduces hunger for several hours. It also slows gastric emptying, which prolongs the feeling of fullness.
Beyond appetite control, GLP-1 stimulates the pancreas to release insulin exactly when blood sugar levels rise — especially important for people with insulin resistance. It also lowers glucagon release, a hormone that raises blood sugar levels. This dual mechanism helps restore the proper metabolic balance in people with obesity or metabolic disorders.
GIP
GIP (glucose-dependent insulinotropic peptide) is another hormone released after meals. It helps regulate blood sugar levels, but in a different way than GLP-1. GIP enhances the body’s insulin response, particularly after consuming carbohydrates and fats.
It promotes insulin production and improves the cells’ ability to take up glucose, thereby encouraging its use for energy rather than remaining in the circulatory system. Persistently high blood sugar can overload the pancreas, increase systemic inflammation, and accelerate fat accumulation — all factors that increase the risk of diabetes. GIP also suppresses hepatic glucose production and can regulate lipid metabolism by restricting fat storage.
Interestingly, GIP alone has limited effects, but in combination with GLP-1, the results are significantly stronger — leading to better blood sugar regulation and more effective weight loss.
Glucagon
Glucagon is a hormone that functions as an antagonist to insulin. While insulin promotes nutrient storage after eating, glucagon is activated during fasting or when blood sugar levels are low. It triggers the mobilization of internal energy reserves: the breakdown of glycogen in the liver, the initiation of lipolysis (fat loss), and the stimulation of glucose production from amino acids.
When glucagon receptors are artificially activated — as with Retatrutide — the body increases energy expenditure, even at rest. Lipolysis intensifies, so that fat stored in adipose tissue is broken down and used as an energy source.
Retatrutide vs Semaglutide vs Tirzepatide
Semaglutide, Tirzepatide, and Retatrutide all belong to the same drug class — they target hormones involved in appetite, glucose regulation, and energy balance. However, they differ fundamentally in their mechanism of action, and studies show differences in clinical outcomes. If you are considering buying Retatrutide and comparing its cost with other weight loss medications, it is important to understand how these three drugs differ in terms of mechanism of action and efficacy — and which one might best suit your goals.
In short:
- Semaglutide acts on one receptor (GLP-1)
- Tirzepatide targets two (GLP-1 and GIP)
- Retatrutide activates three (GLP-1, GIP, and glucagon)
Medication: Semaglutide | Activated Receptors: GLP-1 | Main Effects: Appetite suppression, delayed gastric emptying, blood sugar control | Average Weight Reduction: Up to ~15% over 68 weeks
Medication: Tirzepatide | Activated Receptors: GLP-1 + GIP | Main Effects: Appetite, blood sugar, insulin response, fat metabolism | Average Weight Reduction: Up to ~22.5% over 72 weeks
Medication: Retatrutide | Activated Receptors: GLP-1 + GIP + Glucagon | Main Effects: All of the above + energy expenditure and enhanced fat burning | Average Weight Reduction: Up to ~24% over 48 weeks
Retatrutide is currently in Phase 3 of clinical trials, with earlier phases already successfully completed. It has shown strong results in human studies without major side effects, making it a promising candidate for future approval as a new medical treatment.
FAQ
What potential benefits does Retatrutide have?
Weight loss, improved blood sugar control, reduced appetite.
Can Retatrutide be combined with anabolic steroids?
Yes, this is possible. Low doses of Retatrutide can be used for appetite control, especially during cutting phases, where it is important to maintain a caloric deficit.
Is Retatrutide safe?
Early studies show that it is generally safe, but long-term data is limited.
Do I need a prescription for Retatrutide?
Yes, it is a prescription medication and requires a doctor’s prescription. If you are comparing the price of Retatrutide or looking for a Retatrutide offer, ordering from us ensures that you receive one of the most competitive offers. However, keep in mind that it is a prescription product and you should be careful when transporting it across borders, as regulations may vary by country.
How quickly will I notice results from Retatrutide?
Appetite reduction can begin within the first 1–2 weeks. Visible weight loss typically occurs after 3–4 weeks, with the full effect building up over several months.



